1223324

WES Pharma Inc. — FEI 3010062344

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 21, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Westminster, MD (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location